BSE filing, NSE: MARICO. Summary written from the filing by ALFA Finder's alert engine.
Marico Ltd: key numbers
- Share price
- ₹769.65
- Market cap
- ₹1,00,070 Cr
- Revenue (annual)
- ₹13,611 Cr
- Net profit (annual)
- ₹1,762 Cr
- P/E (TTM)
- 53.0×Sector 38.6×
- Promoter holding
- 58.83%-0.08% QoQ
- FII holding
- 22.25%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Marico Ltd
All →Marico Business Update
Marico announced 89.3% reduction in Scope 1 and 2 GHG emissions intensity since FY13. It also reported 29.95% Scope 3 reduction and 77.3% renewable energy usage.
Marico Board Meeting Date
Marico Limited will hold a board meeting on November 2, 2026. The board will consider and approve un-audited financial results for the quarter ended September 30, 2026.
Marico Acquisition Worth ₹1,012 Cr
Marico Limited acquired a 24.09% stake in Satiya Nutraceuticals (PLIX brand) for ₹1,012.03 Crores, increasing its total ownership to 84.09%.
- Value
- ₹1,012 Cr
Marico Business Update
Marico released its quarterly operational update for Q2 FY 2026-27, highlighting volume growth trends and business resilience across its domestic and international portfolios.
Marico Management Change
Mr. Rajeev Vasudeva will retire as an Independent Director of Marico Limited effective October 31, 2026. Mr. Bhaskar Bhat will succeed him as Chairman of the NRC.
Marico Employee Stock Options
Marico allotted 15,600 ESOP 2016 shares to eligible grantees upon option exercise. Paid-up capital rose to 130,02,04,050 shares of ₹1 each.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.